Home > Food & Beverages > Eye Health Ingredients Market > Table of Contents

Eye Health Ingredients Market Size - By Ingredient (Lutein, Beta Carotene, Vitamin A), Form (Soft gel, capsule & tablets, Liquid, Powder), Disease Indication (Age related Macular Degeneration, Cataract, Dry Eye Syndrome), Source, End Use & Forecast, 2023 – 2032

  • Report ID: GMI1582
  • Published Date: Oct 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Methodology

1.1.1    Initial data exploration

1.1.2    Statistical model and forecast

1.1.3    Industry insights and validation

1.1.4    Definitions & forecast parameters

1.2    Data sources

1.2.1    Secondary

1.2.2    Primary

Chapter 2   Executive Summary

2.1    Eye health ingredients market 3600 synopsis, 2018 –2032

2.1.1    Business trends

2.1.2    Source trends

2.1.3    Ingredient trends

2.1.4    Form trends

2.1.5    Application trends

2.1.6    Disease indication trends

2.1.7    Regional trends

Chapter 3   Eye Health Ingredients Industry Insights

3.1    Industry segmentation

3.2    Industry growth landscape, 2018 –2032

3.3    Industry ecosystem analysis

3.3.1    Regional profit margin trends

3.3.1.1    North America

3.3.1.2    Europe

3.3.1.3    APAC

3.3.1.4    LATAM

3.3.1.5    MEA

3.3.2    Vendor matrix

3.3.2.1    Raw material suppliers

3.3.2.2    Ingredient manufacturers

3.3.2.3    Geographical footprint

3.3.2.4    Production capacity of key players

3.3.3    Distribution channel analysis

3.3.3.1    Supermarkets

3.3.3.2    Specialty retail

3.3.3.3    Pharmacy Chains

3.3.3.4    Independent Retailers

3.3.3.5    Internet/ home shopping

3.4    Regional pricing trends

3.4.1    North America

3.4.2    Europe

3.4.3    APAC

3.4.4    LATAM

3.4.5    MEA

3.5    Trade scenario

3.6    Regulatory landscape

3.6.1    Regulation of Color Additives

3.6.1.1    U.S.

3.6.1.2    Europe

3.6.1.3    China

3.6.1.4    APAC

3.7    Regional raw material trends

3.7.1    Lutein

3.7.2    Zeaxanthin

3.7.3    Beta Carotene

3.7.4    Vitamin A

3.7.5    Bilberry extracts

3.7.6    Others (Capsanthin, Annatto, Omega-3)

3.8    Industry impact forces

3.8.1    Growth drivers

3.8.1.1    Increasing consumer concerns around eye health

3.8.1.2    Nutraceutical industry expansion

3.8.1.3    Increasing AMD disease occurrence among geriatric population

3.8.1.4    Increase in healthcare expenditure leading consumer interest over OTC supplements

3.8.2    Industry pitfalls & challenges

3.8.2.1    Limited availability of lutein and zeaxanthin

3.8.2.2    Harmful health effects from carotenoid consumption

3.9    Eye health ingredients latest product launches

3.9.1    U.S.

3.9.2    Germany

3.9.3    Russia

3.9.4    India

3.9.5    UK

3.9.6    China

3.9.7    Brazil

3.9.8    South Africa

3.10    Growth potential analysis, 2022

3.11    Critical success factors

3.11.1    Role of industry associations

3.11.2    International demographics of declining vision

3.11.3    Consumer behavior towards eye health ingredients

3.11.4    OTC eye care supplements vs prescribed eyecare supplements

3.11.5    Regional consumer insights

3.11.5.1    North America

3.11.5.2    Europe

3.11.5.3    APAC

3.11.5.4    LATAM

3.11.5.5    MEA

3.12    Porter's analysis

3.13    Company market share analysis, 2022

3.13.1    Strategy dashboard

3.14    PESTEL analysis

Chapter 4   Eye Health Ingredients Market, By Source

4.1    Global eye health ingredients market share by source, 2018 & 2032

4.2    Natural

4.2.1    Market estimates and forecast, 2018 –2032

4.2.2    Market estimates and forecast, by region, 2018–2032

4.3    Synthetic

4.3.1    Market estimates and forecast, 2018 –2032

4.3.2    Market estimates and forecast, by region, 2018–2032

Chapter 5   Eye Health Ingredients Market, By Ingredient

5.1    Global eye health ingredients market share by ingredient, 2018 & 2032

5.2    Lutein

5.2.1    Market estimates and forecast, 2018 –2032

5.2.2    Market estimates and forecast, by region, 2018–2032

5.3    Zeaxanthin

5.3.1    Market estimates and forecast, 2018 –2032

5.3.2    Market estimates and forecast, by region, 2018–2032

5.4    Beta Carotene

5.4.1    Market estimates and forecast, 2018 –2032

5.4.2    Market estimates and forecast, by region, 2018–2032

5.5    Vitamin A

5.5.1    Market estimates and forecast, 2018 –2032

5.5.2    Market estimates and forecast, by region, 2018–2032

5.6    Bilberry extracts

5.6.1    Market estimates and forecast, 2018 –2032

5.6.2    Market estimates and forecast, by region, 2018–2032

5.7    Others (Vitamin C, Vitamin E, Zinc & Omega-3 fatty acids, Astaxanthin)

5.7.1    Market estimates and forecast, 2018 –2032

5.7.2    Market estimates and forecast, by region, 2018–2032

Chapter 6   Eye Health Ingredients Market, By Form

6.1    Global eye health ingredients market share by form, 2018 & 2032

6.2    Soft gel, capsule & tablets

6.2.1    Market estimates and forecast, 2018 –2032

6.2.2    Market estimates and forecast, by region, 2018–2032

6.3    Liquid

6.3.1    Market estimates and forecast, 2018 –2032

6.3.2    Market estimates and forecast, by region, 2018–2032

6.4    Powder

6.4.1    Market estimates and forecast, 2018 –2032

6.4.2    Market estimates and forecast, by region, 2018–2032

Chapter 7   Eye Health Ingredients Market, By Application

7.1    Global eye health ingredients market share by application, 2018 & 2032

7.2    Human

7.2.1    Market estimates and forecast, 2018 –2032

7.2.2    Market estimates and forecast, by region, 2018–2032

7.3    Animal

7.3.1    Market estimates and forecast, 2018 –2032

7.3.2    Market estimates and forecast, by region, 2018–2032

Chapter 8   Eye Health Ingredients Market, By Disease Indication

8.1    Global eye health ingredients market share by disease indication, 2018 & 2032

8.2    Age related macular degeneration

8.2.1    Market estimates and forecast, 2018 –2032

8.2.2    Market estimates and forecast, by region, 2018–2032

8.3    Cataract

8.3.1    Market estimates and forecast, 2018 –2032

8.3.2    Market estimates and forecast, by region, 2018–2032

8.4    Dry eye syndrome

8.4.1    Market estimates and forecast, 2018 –2032

8.4.2    Market estimates and forecast, by region, 2018–2032

8.5    Other indications

8.5.1    Market estimates and forecast, 2018 –2032

8.5.2    Market estimates and forecast, by region, 2018–2032

Chapter 9   Eye Health Ingredients Market, By Region

9.1    Global eye health ingredients market share by region, 2018 & 2032

9.2    North America

9.2.1    Market estimates and forecast, 2018 – 2032

9.2.2    Market estimates and forecast, by source, 2018 – 2032

9.2.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.2.4    Market estimates and forecast, by form, 2018 – 2032

9.2.5    Market estimates and forecast, by application, 2018 – 2032

9.2.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.2.7    U.S.

9.2.7.1    Market estimates and forecast, 2018 – 2032

9.2.7.2    Market estimates and forecast, by source, 2018 – 2032

9.2.7.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.2.7.4    Market estimates and forecast, by form, 2018 – 2032

9.2.7.5    Market estimates and forecast, by application, 2018 – 2032

9.2.7.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.2.8    Canada

9.2.8.1    Market estimates and forecast, 2018 – 2032

9.2.8.2    Market estimates and forecast, by source, 2018 – 2032

9.2.8.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.2.8.4    Market estimates and forecast, by form, 2018 – 2032

9.2.8.5    Market estimates and forecast, by application, 2018 – 2032

9.2.8.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.3    Europe

9.3.1    Market estimates and forecast, 2018 – 2032

9.3.2    Market estimates and forecast, by source, 2018 – 2032

9.3.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.3.4    Market estimates and forecast, by form, 2018 – 2032

9.3.5    Market estimates and forecast, by application, 2018 – 2032

9.3.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.3.7    Germany

9.3.7.1    Market estimates and forecast, 2018 – 2032

9.3.7.2    Market estimates and forecast, by source, 2018 – 2032

9.3.7.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.3.7.4    Market estimates and forecast, by form, 2018 – 2032

9.3.7.5    Market estimates and forecast, by application, 2018 – 2032

9.3.7.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.3.8    UK

9.3.8.1    Market estimates and forecast, 2018 – 2032

9.3.8.2    Market estimates and forecast, by source, 2018 – 2032

9.3.8.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.3.8.4    Market estimates and forecast, by form, 2018 – 2032

9.3.8.5    Market estimates and forecast, by application, 2018 – 2032

9.3.8.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.3.9    France

9.3.9.1    Market estimates and forecast, 2018 – 2032

9.3.9.2    Market estimates and forecast, by source, 2018 – 2032

9.3.9.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.3.9.4    Market estimates and forecast, by form, 2018 – 2032

9.3.9.5    Market estimates and forecast, by application, 2018 – 2032

9.3.9.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.3.10    Italy

9.3.10.1    Market estimates and forecast, 2018 – 2032

9.3.10.2    Market estimates and forecast, by source, 2018 – 2032

9.3.10.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.3.10.4    Market estimates and forecast, by form, 2018 – 2032

9.3.10.5    Market estimates and forecast, by application, 2018 – 2032

9.3.10.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.3.11    Russia

9.3.11.1    Market estimates and forecast, 2018 – 2032

9.3.11.2    Market estimates and forecast, by source, 2018 – 2032

9.3.11.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.3.11.4    Market estimates and forecast, by form, 2018 – 2032

9.3.11.5    Market estimates and forecast, by application, 2018 – 2032

9.3.11.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.4    Asia Pacific

9.4.1    Market estimates and forecast, 2018 – 2032

9.4.2    Market estimates and forecast, by source, 2018 – 2032

9.4.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.4.4    Market estimates and forecast, by form, 2018 – 2032

9.4.5    Market estimates and forecast, by application, 2018 – 2032

9.4.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.4.7    China

9.4.7.1    Market estimates and forecast, 2018 – 2032

9.4.7.2    Market estimates and forecast, by source, 2018 – 2032

9.4.7.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.4.7.4    Market estimates and forecast, by form, 2018 – 2032

9.4.7.5    Market estimates and forecast, by application, 2018 – 2032

9.4.7.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.4.8    India

9.4.8.1    Market estimates and forecast, 2018 – 2032

9.4.8.2    Market estimates and forecast, by source, 2018 – 2032

9.4.8.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.4.8.4    Market estimates and forecast, by form, 2018 – 2032

9.4.8.5    Market estimates and forecast, by application, 2018 – 2032

9.4.8.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.4.9    South Korea

9.4.9.1    Market estimates and forecast, 2018 – 2032

9.4.9.2    Market estimates and forecast, by source, 2018 – 2032

9.4.9.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.4.9.4    Market estimates and forecast, by form, 2018 – 2032

9.4.9.5    Market estimates and forecast, by application, 2018 – 2032

9.4.9.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.4.10    Japan

9.4.10.1    Market estimates and forecast, 2018 – 2032

9.4.10.2    Market estimates and forecast, by source, 2018 – 2032

9.4.10.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.4.10.4    Market estimates and forecast, by form, 2018 – 2032

9.4.10.5    Market estimates and forecast, by application, 2018 – 2032

9.4.10.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.5    Latin America

9.5.1    Market estimates and forecast, 2018 – 2032

9.5.2    Market estimates and forecast, by source, 2018 – 2032

9.5.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.5.4    Market estimates and forecast, by form, 2018 – 2032

9.5.5    Market estimates and forecast, by application, 2018 – 2032

9.5.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.5.7    Brazil

9.5.7.1    Market estimates and forecast, 2018 – 2032

9.5.7.2    Market estimates and forecast, by source, 2018 – 2032

9.5.7.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.5.7.4    Market estimates and forecast, by form, 2018 – 2032

9.5.7.5    Market estimates and forecast, by application, 2018 – 2032

9.5.7.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.5.8    Mexico

9.5.8.1    Market estimates and forecast, 2018 – 2032

9.5.8.2    Market estimates and forecast, by source, 2018 – 2032

9.5.8.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.5.8.4    Market estimates and forecast, by form, 2018 – 2032

9.5.8.5    Market estimates and forecast, by application, 2018 – 2032

9.5.8.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.5.9    Argentina

9.5.9.1    Market estimates and forecast, 2018 – 2032

9.5.9.2    Market estimates and forecast, by source, 2018 – 2032

9.5.9.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.5.9.4    Market estimates and forecast, by form, 2018 – 2032

9.5.9.5    Market estimates and forecast, by application, 2018 – 2032

9.5.9.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.6    Middle East & Africa (MEA)

9.6.1    Market estimates and forecast, 2018 – 2032

9.6.2    Market estimates and forecast, by source, 2018 – 2032

9.6.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.6.4    Market estimates and forecast, by form, 2018 – 2032

9.6.5    Market estimates and forecast, by application, 2018 – 2032

9.6.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.6.7    Saudi Arabia

9.6.7.1    Market estimates and forecast, 2018 – 2032

9.6.7.2    Market estimates and forecast, by source, 2018 – 2032

9.6.7.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.6.7.4    Market estimates and forecast, by form, 2018 – 2032

9.6.7.5    Market estimates and forecast, by application, 2018 – 2032

9.6.7.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.6.8    UAE

9.6.8.1    Market estimates and forecast, 2018 – 2032

9.6.8.2    Market estimates and forecast, by source, 2018 – 2032

9.6.8.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.6.8.4    Market estimates and forecast, by form, 2018 – 2032

9.6.8.5    Market estimates and forecast, by application, 2018 – 2032

9.6.8.6    Market estimates and forecast, by disease indication, 2018 – 2032

9.6.9    South Africa

9.6.9.1    Market estimates and forecast, 2018 – 2032

9.6.9.2    Market estimates and forecast, by source, 2018 – 2032

9.6.9.3    Market estimates and forecast, by ingredient, 2018 – 2032

9.6.9.4    Market estimates and forecast, by form, 2018 – 2032

9.6.9.5    Market estimates and forecast, by application, 2018 – 2032

9.6.9.6    Market estimates and forecast, by disease indication, 2018 – 2032

Chapter 10   Company Profiles

10.1    Allied Biotech Corporation

10.1.1    Business Overview

10.1.2    Financial Data

10.1.3    Concentrations Landscape

10.1.4    Strategic Outlook

10.1.5    SWOT Analysis

10.2    BASF

10.2.1    Business Overview

10.2.2    Financial Data

10.2.3    Concentrations Landscape

10.2.4    Strategic Outlook

10.2.5    SWOT Analysis

10.3    DSM

10.3.1    Business Overview

10.3.2    Financial Data

10.3.3    Concentrations Landscape

10.3.4    Strategic Outlook

10.3.5    SWOT Analysis

10.4    Kemin

10.4.1    Business Overview

10.4.2    Financial Data

10.4.3    Concentrations Landscape

10.4.4    Strategic Outlook

10.4.5    SWOT Analysis

10.5    Tianjin Pharmaland Technology

10.5.1    Business Overview

10.5.2    Financial Data

10.5.3    Concentrations Landscape

10.5.4    Strategic Outlook

10.5.5    SWOT Analysis

10.6    American River Nutrition, Inc

10.6.1    Business Overview

10.6.2    Financial Data

10.6.3    Concentrations Landscape

10.6.4    Strategic Outlook

10.6.5    SWOT Analysis

10.7    Archer Daniels Midland Company

10.7.1    Business Overview

10.7.2    Financial Data

10.7.3    Concentrations Landscape

10.7.4    Strategic Outlook

10.7.5    SWOT Analysis

10.8    Vitae Naturals

10.8.1    Business Overview

10.8.2    Financial Data

10.8.3    Concentrations Landscape

10.8.4    Strategic Outlook

10.8.5    SWOT Analysis

10.9    Davos life Science

10.9.1    Business Overview

10.9.2    Financial Data

10.9.3    Concentrations Landscape

10.9.4    Strategic Outlook

10.9.5    SWOT Analysis

10.10    Cargil

10.10.1    Business Overview

10.10.2    Financial Data

10.10.3    Concentrations Landscape

10.10.4    Strategic Outlook

10.10.5    SWOT Analysis

10.11    Wilmer Spring Fruit Nutrition Products Co. Ltd

10.11.1    Business Overview

10.11.2    Financial Data

10.11.3    Concentrations Landscape

10.11.4    Strategic Outlook

10.11.5    SWOT Analysis

10.12    FMC corporation

10.12.1    Business Overview

10.12.2    Financial Data

10.12.3    Concentrations Landscape

10.12.4    Strategic Outlook

10.12.5    SWOT Analysis

10.13    Vidya Europe SAS

10.13.1    Business Overview

10.13.2    Financial Data

10.13.3    Concentrations Landscape

10.13.4    Strategic Outlook

10.13.5    SWOT Analysis

Chapter 11   Potential Customer Profiles

11.1    Amway

11.1.1    Business Overview

11.1.2    Financial Data

11.1.3    Concentrations Landscape

11.1.4    Strategic Outlook

11.2    Solgar

11.2.1    Business Overview

11.2.2    Financial Data

11.2.3    Concentrations Landscape

11.2.4    Strategic Outlook

11.3    Life extension

11.3.1    Business Overview

11.3.2    Financial Data

11.3.3    Concentrations Landscape

11.3.4    Strategic Outlook

11.4    Jarrow Formulas

11.4.1    Business Overview

11.4.2    Financial Data

11.4.3    Concentrations Landscape

11.4.4    Strategic Outlook

11.5    NOW Foods

11.5.1    Business Overview

11.5.2    Financial Data

11.5.3    Concentrations Landscape

11.5.4    Strategic Outlook

11.6    Natures’s Life

11.6.1    Business Overview

11.6.2    Financial Data

11.6.3    Concentrations Landscape

11.6.4    Strategic Outlook

11.7    Nutrovea

11.7.1    Business Overview

11.7.2    Financial Data

11.7.3    Concentrations Landscape

11.7.4    Strategic Outlook

11.8    Natures Lab

11.8.1    Business Overview

11.8.2    Financial Data

11.8.3    Concentrations Landscape

11.8.4    Strategic Outlook

11.9    Zenith Nutrition

11.9.1    Business Overview

11.9.2    Financial Data

11.9.3    Concentrations Landscape

11.9.4    Strategic Outlook

11.10    Blubonnet Nutrition

11.10.1    Business Overview

11.10.2    Financial Data

11.10.3    Concentrations Landscape

11.10.4    Strategic Outlook

11.11    Sirulina

11.11.1    Business Overview

11.11.2    Financial Data

11.11.3    Concentrations Landscape

11.11.4    Strategic Outlook

11.12    Caps Extra

11.12.1    Business Overview

11.12.2    Financial Data

11.12.3    Concentrations Landscape

11.12.4    Strategic Outlook

11.13    MacuShield

11.13.1    Business Overview

11.13.2    Financial Data

11.13.3    Concentrations Landscape

11.13.4    Strategic Outlook

11.14    PreserVision

11.14.1    Business Overview

11.14.2    Financial Data

11.14.3    Concentrations Landscape

11.14.4    Strategic Outlook

11.15    Efalex

11.15.1    Business Overview

11.15.2    Financial Data

11.15.3    Concentrations Landscape

11.15.4    Strategic Outlook

11.16    BioCare NutriGuard

11.16.1    Business Overview

11.16.2    Financial Data

11.16.3    Concentrations Landscape

11.16.4    Strategic Outlook

11.17    Futurebiotics

11.17.1    Business Overview

11.17.2    Financial Data

11.17.3    Concentrations Landscape

11.17.4    Strategic Outlook

11.18    Swanson Products

11.18.1    Business Overview

11.18.2    Financial Data

11.18.3    Concentrations Landscape

11.18.4    Strategic Outlook

11.19    Davis Vision

11.19.1    Business Overview

11.19.2    Financial Data

11.19.3    Concentrations Landscape

11.19.4    Strategic Outlook

11.20    Alcon

11.20.1    Business Overview

11.20.2    Financial Data

11.20.3    Concentrations Landscape

11.20.4    Strategic Outlook

11.21    Pfizer Inc.

11.21.1    Business Overview

11.21.2    Financial Data

11.21.3    Concentrations Landscape

11.21.4    Strategic Outlook

11.22    Vitabiotics Ltd.

11.22.1    Business Overview

11.22.2    Financial Data

11.22.3    Concentrations Landscape

11.22.4    Strategic Outlook

11.23    Valeant Pharmaceuticals International Inc.

11.23.1    Business Overview

11.23.2    Financial Data

11.23.3    Concentrations Landscape

11.23.4    Strategic Outlook

11.24    Alliance Pharma

11.24.1    Business Overview

11.24.2    Financial Data

11.24.3    Concentrations Landscape

11.24.4    Strategic Outlook

11.25    The Nature's Bounty Co

11.25.1    Business Overview

11.25.2    Financial Data

11.25.3    Concentrations Landscape

11.25.4    Strategic Outlook

11.26    Novartis AG

11.26.1    Business Overview

11.26.2    Financial Data

11.26.3    Concentrations Landscape

11.26.4    Strategic Outlook
 

Authors: Kunal Ahuja, Tushar Malkani

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 39
  • Tables & Figures: 329
  • Countries covered: 25
  • Pages: 300
 Download PDF